Target intelligence / Profile preview

Dentin collagen and collagenolytic enzymes (Matrix Metalloproteinases and Cysteine Cathepsins)

Molecular classification
Structural protein, Enzyme, Matrix metalloproteinase, Cysteine protease
01

Overview

Dentin collagen, primarily Type I collagen, constitutes approximately 90% of the organic matrix of dentin and provides the structural framework for tooth mineralization (Mazzoni et al., 2015). Sequestrated within this mineralized matrix are endogenous collagenolytic enzymes, including matrix metalloproteinases (MMPs-2, -8, -9, and -20) and cysteine cathepsins (Cathepsins B and K) (Tjäderhane et al., 1998; Tersariol et al., 2010). These enzymes are typically inactive but can be activated by the acidic environment produced by cariogenic bacteria or by the acid-etching procedures used in adhesive dentistry (Pashley et al., 2004). Once activated, these proteases degrade the collagen fibrils, which is a primary cause of the degradation of the resin-dentin hybrid layer and the progression of dental caries (Carrilho et al., 2007). Therapeutic interventions aim to preserve the integrity of the dentin matrix by using protease inhibitors like chlorhexidine or collagen cross-linkers like carbodiimides (Mazzoni et al., 2014). These strategies are crucial for improving the clinical longevity of dental restorations and managing deep carious lesions.

Other names
Dentin organic matrixDentin MMPsDentin cathepsinsType I collagen in dentinDentin matrix proteases
02

Mechanism of action

Inhibition of endogenous matrix metalloproteinases (MMPs) and cysteine cathepsins through competitive or non-competitive binding, and stabilization of the dentin collagen matrix via chemical cross-linking to prevent proteolytic degradation.

03

Biological functions

Structural supportTissue remodelingMineralizationProteolysisExtracellular matrix organization
04

Disease associations

Dental cariesRestoration failureDentin hypersensitivityPeriodontitis
05

Safety considerations

Potential cytotoxicity to dental pulp cellsLeaching of inhibitory agents into the oral environmentLong-term stability of the inhibitor-collagen complex under mechanical stress
06

Interacting drugs

Chlorhexidine

5 more in the full profile.

07

Biomarkers

C-terminal telopeptide of type I collagen (ICTP)C-terminal cross-linked telopeptide (CTX)MMP-8 levels in dentinal fluid

Beyond the preview

Go deeper on Dentin collagen and collagenolytic enzymes (Matrix Metalloproteinases and Cysteine Cathepsins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dentin collagen and collagenolytic enzymes (Matrix Metalloproteinases and Cysteine Cathepsins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call